Post-Traumatic Stress Disorder Market: Analysis of the Epidemiology, Pipeline Therapies, and Key Companies Operating in the Market – Digital Journal

DelveInsight’s Post-Traumatic Stress Disorder (PTSD)-Market Insights, Epidemiology, and Market Forecast-2032 report provides an in-depth understanding of Post-Traumatic Stress Disorder (PTSD), historical and forecast epidemiology, and Post-Traumatic Stress Disorder (PTSD) market trends in the United States , EU5 (Germany, Spain, Italy, France and UK) and Japan.

DelveInsights Post-Traumatic Stress Disorder (PTSD)- Market Insights, Epidemiology and Market Forecast-2032 rThe report provides an in-depth understanding of Post Traumatic Stress Disorder (PTSD), historical and forecast epidemiology, as well as Post Traumatic Stress Disorder (PTSD) market trends in United States, EU5 (Germany, Spain, Italy, France). , and United Kingdom) and Japan.

The Post-Traumatic Stress Disorder (PTSD) Market report provides current treatment practices, new drugs, market share of each Post-Traumatic Stress Disorder (PTSD) therapy, and current and forecast Post-Traumatic Stress Disorder (PTSD) market size from 2019 to 2032 segmented by seven major markets. The report also covers current Post Traumatic Stress Disorder (PTSD) treatment practices/algorithms, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying market potential.

Some of the key facts about Post Traumatic Stress Disorder market:

• Participants with lifelong PTSD have higher rates of psychopathology (including major depressive episodes, behavioral disorders, and alcohol dependence), risk events for self-harm, attempted suicide, violent crime, and functional impairment. There is a need to comprehensively characterize prevalence, clinical features, and risk factors associated with trauma exposure and subsequent post-traumatic stress disorder (PTSD) in young people.
• Trauma exposure and PTSD in young people are common: 15-82.5% of young people experience traumatic events and 1.3-8.1% experience PTSD in their lifetime. with correspondingly different estimates. However, these estimates come largely from studies conducted in the US using now outdated diagnostic criteria (DSM-III and DSM-IV) (Lewis et al., 2019).

Do You Have Questions? Click here to learn more about the Post Traumatic Stress Disorder Market Landscape

Overview of post-traumatic stress disorder

Post-Traumatic Stress Disorder (PTSD) is a chronic psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, major accident, terrorist attack, war/fight, or rape, death, sexual violence, or are at risk of serious injury. PTSD can affect anyone, regardless of race, nationality, or culture, and at any age. People with PTSD have intense, troubling thoughts and feelings related to their experience that persist long after the traumatic event is over. You can relive the event through flashbacks or nightmares; they may feel sadness, fear, or anger; and they may feel detached or alienated from other people.

PTSD is treated through a combination of psychotherapy and pharmacotherapy. Pharmacotherapy is considered first-line treatment with the use of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. There are a range of psychological treatments or psychotherapies for PTSD, including trauma-focused interventions and non-trauma-focused interventions. Trauma-focused treatments include Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT), and non-trauma-focused treatments include relaxation, stress inoculation training (SIT), and interpersonal therapy.

Insights into the epidemiology of post-traumatic stress disorder

• Trauma exposure and PTSD in young people are common: 15-82.5% of young people experience traumatic events and 1.3-8.1% experience PTSD in their lifetime. with correspondingly different estimates. However, these estimates come largely from studies conducted in the US using now outdated diagnostic criteria (DSM-III and DSM-IV) (Lewis et al., 2019).
• A single-site study by the American Psychiatric Association of the US found that 11.9% of emergency medicine (EM) residents met criteria for PTSD, with 30% having symptoms that did not meet the threshold for diagnosis. A study of emergency physician EPs and advanced practice providers from a group practice in the US found a 12.7% PTSD prevalence.
• In a recent publication by Spottswood et al. (2017), the National Comorbidity Survey Replication (NCS-R), one of the largest epidemiological studies of mental disorders conducted in the general population of the United States, the lifetime prevalence of PTSD in adults is 6.8% and the annual prevalence 3 .5%.

Post-Traumatic Stress Disorder Epidemiology Segmentation

• Total post-traumatic stress disorder predominant cases
• Gender-specific cases throughout post-traumatic stress disorder
• Microbiology-specific cases throughout Post-Traumatic Stress Disorder
• Total post-traumatic stress disorder age-specific cases

Post Traumatic Stress Disorder Market Outlook

The report’s Post Traumatic Stress Disorder (PTSD) Market Outlook helps build a detailed understanding of historical, current, and forecast Post Traumatic Stress Disorder (PTSD) market trends by analyzing the impact of current therapies on the market needs, drivers, and barriers, and demand for better technology. This segment provides a detailed overview of the Post-Traumatic Stress Disorder (PTSD) market trend for each marketed drug and late-stage pipeline therapy by assessing their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action and compliance rate, growing market demand, growing patient pool, patient segment covered, expected launch year, competition from other therapies, brand equity, its impact on the market, and key opinion leaders assessment. The calculated market data is presented with relevant tables and graphs to give a clear picture of the market at first glance. According to DelveInsight, the Post Traumatic Stress Disorder (PTSD) market in 7MM is expected to experience a major change during the study period 2019-2032.

Learn more by requesting a sample @ Post-Traumatic Stress Disorder Market

Key company for post-traumatic stress disorder

• Nobilis therapeutics
• Otsuka Pharma
• compass paths
• And many more

Therapies for post-traumatic stress disorder

• BTX001
• brexpiprazole
• COMP360
• And many more

Table of Contents

• Important Findings
• Report introduction
• Post-Traumatic Stress Disorder Summary
• Disease background and overview
• Epidemiology and patient population
• The United States
• EU5
• New therapies for post-traumatic stress disorder
• Post Traumatic Stress Disorder Market Outlook
• Market access and reimbursement of therapies
• Appendix
• Methodology of the Post-Traumatic Stress Disorder Report
• DelveInsight features
• Disclaimer

Click here to learn more about Post Traumatic Stress Disorder

media contact
Name of the company: DelveInsight Business Research
Interlocutor: Aja Kaul
E-mail: Send e-mail
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
Federal State: NV
Country: United States
Website: https://www.delveinsight.com/